COMPARATIVE ANALYSIS OF SKIN FUNGAL COLONIZATION IN PATIENTS WITH ATOPIC DERMATITIS AND HEALTHY INDIVIDUALS

Atopic dermatitis is a chronic, relapsing inflammatory skin disease. Immune dysregulation occurs, leading to inflammation in response to allergens that penetrate through a compromised epidermal barrier. Defects in the skin barrier and inflammatory processes in the skin result in increased colonization by conditionally pathogenic microorganisms. Fungal microbiota dysbiosis (Malassezia spp. and others) is considered one of the factors involved in the pathogenesis of atopic dermatitis. However, the influence of fungal microflora on atopic dermatitis remains less studied compared to the role of bacterial microorganisms. The aim of this study was to conduct a comparative analysis of the prevalence of fungi in patients with atopic dermatitis and a control group using real-time polymerase chain reaction. The study included 151 participants. The group of patients with atopic dermatitis included lesions from different locations, and for more accurate comparison. The control group was formed considering both dry skin areas and areas with increased sebum production. All patients had their diagnosis of atopic dermatitis confirmed according to clinical guidelines. Disease severity was assessed using the SCORAD index. Epithelial scrapings were collected depending on lesion location. The obtained skin samples were analyzed using real-time PCR. It was found that patients with atopic dermatitis exhibited significantly higher levels of fungal colonization compared to the control group. Specifically, patients with atopic dermatitis more frequently harbored various yeast species such as Candida, Malassezia, and Saccharomyces cerevisiae, as well as non-dermatophyte molds like Aspergillus spp./Penicillium spp. Additionally, we observed that the distribution of Candida and Malassezia restricta species varies depending on the severity of atopic dermatitis. Changes in the fungal composition of the skin play an important role in the pathogenesis of atopic dermatitis, potentially activating the immune system and exacerbating inflammatory processes. Although fungi are not direct causative agents of atopic dermatitis, an imbalance in their populations likely contributes to disease exacerbation and progression. Further research is needed to better understand how fungi influence atopic dermatitis development particularly studies focusing on immune responses to fungi and allergy mechanisms related to their alterations. Such data could aid in developing new therapeutic and preventive strategies for this condition.

1. Gonsorunova D.S., Ogorodova L.M., Fyodorova O.S., Kamaltynova Ye.M., Belonogova Ye.G., Kremer Ye.E. Т-regulatory cells in atopic dermatitis immune response. Bull Sib Med, 2011, Vol. 10, no. 4, pp. 82-88.

2. Russian Society of Dermatovenerologists and Cosmetologists; Russian Association of Allergists and Clinical Immunologists; Union of Pediatricians of Russia. Atopic Dermatitis: Clinical Guidelines, 2023.

3. Savcheno N.V., Kornilov D.O., Simarzina V.M., Tryapitsyn M.A., Nechaeva D.M., Bekhter A.A., Itani T.M., Zornikov D.L., Voroshilina E.S. Pilot study on real-time PCR capabilities for the detection of opportunistic microorganisms in skin microbiome samples. USMU Med Bull, 2024, no. 2, pp. 61-74.

4. Sokolova T.V., Safonova L.A., Klivitskaya N.A. Medical mistakes in tactics of management of patients with atopic dermatitis associated with opportunistic yeast microflora infection. Russ J Clin Dermatol Venereol, 2016, Vol. 15, no. 2, pp. 59-71.

5. Chernushevich D.D., Elisyutina O.G., Fedenko E.S. Skin microbiome and modern treatment options for complicated forms of atopic dermatitis. Russ J Allergy, 2023, Vol. 20, no. 1, pp. 63-73.

6. Arzumanyan V.G., Magarshak O.O., Semenov B.F. Yeast fungi in patients with allergic diseases: species variety and sensitivity to antifungal drugs. Bull Exp Biol Med, 2000, Vol. 129, pp. 601–604.

7. Cabañes F.J. Malassezia yeasts: how many species infect humans and animals? PLoS Pathog, 2014, Vol. 10, e1003892.

8. Choi Y., Park K.Y., Han H.S., Lee M.-K., Seo S.J. Comparative Analysis of Cutaneous Fungi in Atopic Dermatitis Patients and Healthy Individuals. Ann Dermatol, 2022, Vol. 34, no. 2, pp. 118-124.

9. Chong A.C., Navarro-Triviño F.J., Su M., Park C.O. Fungal Head and Neck Dermatitis: Current Understanding and Management. Clin Rev Allergy Immunol, 2024, Vol. 66, no. 3, pp. 363–375.

10. Cork M.J., Danby S.G., Vasilopoulos Y., Hadgraft J., Lane M.E., Moustafa M., Guy R.H., Macgowan A.L., Tazi-Ahnini R., Ward S.J. Epidermal barrier dysfunction in atopic dermatitis. J Invest Dermatol, 2009, Vol. 129, pp. 1892–1908.

11. Costello E.K., Lauber C.L., Hamady M., Fierer N., Gordon J.I., Knight R. Bacterial community variation in human body habitats across space and time. Science, 2009, Vol. 326, pp. 1694–1697

12. Czarnowicki T., Krueger J., Guttman-Yassky E. Novel concepts of prevention and treatment of atopic dermatitis through barrier and immune manipulations with implications for the atopic march. J Allergy Clin Immunol, 2017, Vol. 139, pp. 1723–1734.

13. De Benedetto A., Kubo A., Beck L.A. Skin barrier disruption: A requirement for allergen sensitization? J Investig Dermatol, 2012, Vol. 132, pp. 949–963.

14. De Freitas R.S., Neves P.S., Charbel C.E., Criado P.R., Nunes R.S., Santos-Filho A.M., Vasconcellos C. Investigation of superficial mycosis in cutaneous allergy patients using topical or systemic corticosteroids. Int J Dermatol, 2017, Vol. 56, no. 10, pp. 194–198.

15. Edslev S.M., Andersen P.S., Agner T., Saunte D.M.L., Ingham A.C., Johannesen T.B., Clausen M.L. Identification of cutaneous fungi and mites in adult atopic dermatitis: analysis by targeted 18S rRNA amplicon sequencing. BMC Microbiol, 2021, Vol. 21, p. 72

16. Faergemann J. Atopic dermatitis and fungi. Clin. Microbiol. Rev., 2002, Vol. 15, pp. 545–563.

17. Findley K., Oh J., Yang J., Conlan S., Deming C., Meyer J.A., Schoenfeld D., Nomicos E., Park M., Kong H.H., Segre J.A. Topographic diversity of fungal and bacterial communities in human skin. Nature, 2013, Vol. 498, pp. 367–370.

18. Fleming P., Drucker A.M. Risk of infection in patients with atopic dermatitis treated with dupilumab: a meta-analysis of randomized controlled trials. J. Am. Acad. Dermatol., 2018, Vol. 78, no. 1, pp. 62–69.

19. Ghaffari J., Taheri Sarvtin M., Hedayati M.T., Hajheydari Z., Yazdani J., Shokohi T. Evaluation of Candida colonization and specific humoral responses against Candida albicans in patients with atopic dermatitis. Biomed. Res. Int., 2015, Vol. 2015, pp. 142453.

20. Glatz M., Bosshard P.P., Hoetzenecker W., Schmid-Grendelmeier P. The role of Malassezia spp. in atopic dermatitis. J. Clin. Med., 2015, Vol. 4, pp. 1217-1228.

21. Glatz M., Buchner M., von Bartenwerffer W., Schmid-Grendelmeier P.S., Worm M., Hedderich J., Fölster-Holst R. Malassezia spp. specific immunoglobulin E level is a marker for severity of atopic dermatitis in adults. Acta Derm. Venereol., 2015, Vol. 95, pp. 191-196.

22. Han S.H., Cheon H.I., Hur M.S., Kim M.J., Jung W.H., Lee Y.W., Choe Y.B., Ahn K.J. Analysis of the skin mycobiome in adult patients with atopic dermatitis. Exp. Dermatol., 2018, Vol. 27, pp. 366-373.

23. Hassan S., Poulos C., Bhatti J., Rangwani S., Khan Z., Mahmoud A., Mohammed T.O. Saccharomyces cerevisiae as a skin physiology, pathology, and treatment model. Dermatol. Online J., 2020, Vol. 26, no. 11.

24. Javad G., Taheri Sarvtin M., Hedayati M.T., Hajheydari Z., Yazdani J., Shokohi T. Evaluation of Candida colonization and specific humoral responses against Candida albicans in patients with atopic dermatitis. Biomed Res Int, 2015, Vol. 2015, pp. 849206.

25. Kaga M., Sugita T., Nishikawa A., Wada Y., Hiruma M., Ikeda S. Molecular analysis of the cutaneous Malassezia microbiota from the skin of patients with atopic dermatitis of different severities. Mycoses, 2011, Vol. 54, pp. e24–e28.

26. Karvonen A.M., Hyvärinen A., Korppi M., Haverinen-Shaughnessy U., Renz H., Pfefferle P.I. et al. Moisture damage and asthma: a birth cohort study. Pediatrics, 2015, Vol. 135, no. 3, pp. e598–e606.

27. Kunz B., Oranje A.P., Labreze L., Stalder J.F., Ring J., Taieb A. Clinical validation and guidelines for the SCORAD index: consensus report of the European task force on atopic dermatitis. Dermatol., 1997, Vol. 195, pp. 10–19.

28. Laughter M.R., Maymone M.B.C., Mashayekhi S., Arents B.W.M., Karimkhani C., Langan S.M. et al. The global burden of atopic dermatitis: lessons from the Global Burden of Disease Study 1990–2017. Br J Dermatol, 2021, Vol. 184, no. 2, pp. 304–309.

29. Lee J.Y., Seo J.H., Kwon J.W., Yu J., Kim B.J., Lee S.Y., Kim H.-B., Kim W.-K., Kim K.-W., Shin Y.-J., S.-J. Exposure to gene-environment interactions before 1 year of age may favor the development of atopic dermatitis. Int Arch Allergy Immunol, 2012, Vol. 157, no. 4, pp. 363–371.

30. Lintu P., Savolainen J., Kortekangas-Savolainen O., Kalimo K. Systemic ketoconazole is an effective treatment of atopic dermatitis with IgE-mediated hypersensitivity to yeasts. Allergy, 2001, Vol. 56, pp. 512–517.

31. Lübbe J. Secondary infections in patients with atopic dermatitis. Am J Clin. Dermatol, 2003, Vol. 4, no. 9, pp. 641–654.

32. Meylan P., Lang C., Mermoud S., Johannsen A., Norrenberg S., Hohl D., Vial Y., Prod'hom G., Greub G., Kypriotou M., Christen-Zaech S. Skin Colonization by Staphylococcus aureus Precedes the Clinical Diagnosis of Atopic Dermatitis in Infancy. J Investig Dermatol, 2017, Vol. 137, pp. 2497–2504.

33. Montero-Vilchez T., Segura-Fernández-Nogueras M.V., Pérez-Rodríguez I., Soler-Gongora M., Martinez-Lopez A., Fernández-González A., Molina-Leyva A., Arias-Santiago S. Skin Barrier Function in Psoriasis and Atopic Dermatitis: Transepidermal Water Loss and Temperature as Useful Tools to Assess Disease Severity. J Clin Med, 2021, Vol. 10, no. 2, p. 359.

34. Oh J., Byrd A.L., Deming C., Conlan S., Program N.C.S., Kong H.H., Segre J.A. Biogeography and individuality shape function in the human skin metagenome. Nature, 2014, Vol. 514, pp. 59-64.

35. Paller A.S., Kong H.H., Seed P., Naik S., Scharschmidt T.C., Gallo R.L., Luger T., Irvine A.D. The microbiome in patients with atopic dermatitis. J. Allergy Clin. Immunol., 2019, Vol. 143, pp. 26-35.

36. Palmer C.N., Irvine A.D., Terron-Kwiatkowski A., Zhao Y., Liao H., Lee S.P., Goudie D.R., Sandilands A., Campbell L.E., Smith F.J., O'Regan G.M., Watson R.M., Cecil J.E., Bale S.J., Compton J.G., DiGiovanna J.J., Fleckman P., Lewis-Jones S., Arseculeratne G., Sergeant A., Munro C.S., El Houate B., McElreavey K., Halkjaer L.B., Bisgaard H., Mukhopadhyay S., McLean W.H. Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat Genet, 2006, Vol. 38, pp. 441-446.

37. Park A., Lee E., Park M.-N., Lee J., Song K.B., Yoon J. Innate Type 2 Response to Aspergillus fumigatus in a Murine Model of Atopic Dermatitis–like Skin Inflammation. J Korean Med Sci, 2021, Vol. 36, no. 40, pp. 261.

38. Prohic A., Jovovic Sadikovic T., Krupalija-Fazlic M., Kuskunovic-Vlahovljak S. Malassezia species in healthy skin and in dermatological conditions. Int J Dermatol, 2016, Vol. 55, no. 5, pp. 494-504.

39. Reponen T., Lockey J., Bernstein D.I., Vesper S.J., Levin L., Khurana Hershey G.K., Zheng S., Ryan P., Grinshpun S.A., Villareal M., Lemasters G. Infant origins of childhood asthma associated with specific molds. J Allergy Clin Immunol, 2012, Vol. 130, no. 3, pp. 639-644.e5.

40. Savolainen J., Lammintausta K., Kalimo K., Viander M. Candida albicans and atopic dermatitis. Clin Exp Allergy, 1993, Vol. 23, no. 4, pp. 332-339.

41. Sharpe R.A., Thornton C.R., Tyrrell J., Nikolaou V., Osborne N.J. Variable risk of atopic disease due to indoor fungal exposure in NHANES 2005-2006. Clin Exp Allergy, 2015, Vol. 45, no. 10, pp. 1566-1578.

42. Tao Z., Jinho Y., Min H.O., Zhu Z. The atopic march: progression from atopic dermatitis to allergic rhinitis and asthma. Allergy Asthma Immunol Res, 2011, Vol. 3, no. 2, pp. 67-73.

43. Thammahong A., Kiatsurayanon C., Edwards S.W., Rerknimitr P., Chiewchengchol D. The clinical significance of fungi in atopic dermatitis. Int J Dermatol, 2020, Vol. 59, pp. 926-935.

44. Weidinger S., Novak N. Atopic dermatitis. Lancet, 2016, Vol. 387, pp. 1109-1122.

45. Zhang E., Tanaka T., Tajima M., Tsuboi R., Kato H., Nishikawa A., Sugita T. Anti-Malassezia-specific IgE antibodies production in Japanese patients with head and neck atopic dermatitis: relationship between the level of specific IgE antibody and the colonization frequency of cutaneous Malassezia species and clinical severity. J Allergy, 2011, p. 645670.

46. Zhang E., Tanaka T., Tajima M., Tsuboi R., Nishikawa A., Sugita T. Characterization of the skin fungal microbiota in patients with atopic dermatitis and in healthy subjects. Microbiol Immunol, 2011, Vol. 55, pp. 625-632.